Vidaya launches a health data aggregation platform that pulls biometric signals from wearables, lab results, and genetic information to calculate a unified "healthspan score." The startup surfaces on Product Hunt, positioning itself in the crowded longevity and preventive health tech space.
The platform targets consumers and health-conscious users who already track fitness data via Apple Watch, Oura Ring, Fitbit, and similar devices but lack a single dashboard that contextualizes all their health inputs. By integrating genetic markers alongside continuous biometric tracking and clinical labs, Vidaya attempts to move beyond fitness metrics into genuine health outcome prediction.
The healthspan score concept differs from lifespan projections. It focuses on quality of remaining years rather than mortality estimates alone. This appeals to the growing biohacking community and wealthy individuals investing in longevity protocols. Companies like Inside Tracker, Levels, and Oura already operate in adjacent spaces. Inside Tracker combines genetics with blood work. Levels focuses on continuous glucose monitoring. Oura emphasizes sleep and recovery data. Vidaya's differentiator appears to be cross-platform consolidation with genetic layering.
The timing aligns with consumer appetite for preventive health data. Apple's health features expand annually. Continuous monitoring devices proliferate. Direct-to-consumer genetic testing normalized after companies like 23andMe went public. Users increasingly own their raw health data but lack tools to synthesize it into actionable intelligence.
Product Hunt represents a traditional launch venue for consumer health apps seeking early adopter feedback. The platform's audience skews technical and health-conscious, making it ideal testing ground before broader consumer or institutional rollout. Vidaya's appearance suggests pre-seed or seed-stage positioning, building community and product-market fit signals before approaching venture investors.
The healthspan aggregation category remains wide open. No dominant player has consolidated the consumer wear
